[1]
2018. Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway. Biomolecules and Biomedicine. 18, 2 (May 2018), 162–169. DOI:https://doi.org/10.17305/bjbms.2018.2400.